Clinical Microbiomics A/S
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Clinical Microbiomics A/S - overview
Established
2015
Location
Copenhagen, -, Denmark
Primary Industry
Biotechnology
About
Based in Copenhagen, Denmark, and founded in 2015, Clinical Microbiomics A/S, a. k. a. Clinical Microbiomics operates as a provider of microbiome research services to study and promote the application of microbiomes in treating diseases.
In October 2022, Clinical Microbiomics A/S raised EUR 10 million from Seventure. As of April 2024, Anders Grøn is the CEO of the company. The company provides specialized services in microbiome and metabolome analysis, employing an interdisciplinary approach to address research inquiries. The firm’s expertise spans data analysis utilizing bioinformatics tools, enabling clients to gain insights into metabolic processes through metabolite profiling.
Clinical Microbiomics partners with academic institutions and biotech, consumer health, and pharma companies to analyze and connect the dots to help find the answers needed to improve healthcare.
Current Investors
Seventure Partners
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Molecular Science, Genetics & Gene Therapy
Website
www.clinical-microbiomics.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.